Reset filters
  • 28 September 2017

US FDA approves nivolumab immunotherapy for liver cancer

Read the article
  • 20 September 2017

Does drug injection equipment other than syringes transmit hepatitis C?

Read the article
  • 15 September 2017

High prices of DAAs mean there's been little progress towards achieving WHO target of eliminating HCV by 2030

Read the article
  • 30 August 2017

The availability of direct-acting antivirals is reducing disparities in the uptake of hepatitis C treatment

Read the article
  • 22 August 2017

Liver fibrosis speeds up around the menopause in women with HIV and HCV co-infection

Read the article
  • 21 August 2017

People with HIV are at risk for liver fibrosis and steatosis

Read the article
  • 17 August 2017

Switching from efavirenz to raltegravir leads to significant improvements in fatty liver disease in people with HIV

Read the article
  • 10 August 2017

Treatment with DAAs reduces the risk of mortality in the first 18 months after the completion of treatment

Read the article
  • 7 August 2017

European and US regulators approve AbbVie's new combo for all hepatitis C genotypes

Read the article

Receive the latest HIV research and conference news

Complete this form to receive regular email bulletins including the latest HIV research and conference news from aidsmap and/or updates from Terrence Higgins Trust.

Get regular email bulletins

Please let us know how you'd like to be contacted by ticking the options below.